Is CinCor Pharma, Inc. (CINC) a Buy, Sell, or Hold?
NASDAQ : CINC
CinCor Pharma, Inc. — Institutional Ownership
$29.06 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 619.3K
- Market Capitalization
- $1.27B
- P/E Ratio
- -20.46
- Dividend Yield
- 0.00%
- Price Target
- $45.50
- Year High
- $43.15
- Year Low
- $10.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.53
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-02-14 | Joseph Edelman | 2.58M | 5.90% |
| 2023-02-14 | Perceptive Life Sciences Master Fund, Ltd. | 2.58M | 5.90% |
| 2023-02-14 | Perceptive Advisors LLC | 2.58M | 5.90% |
| 2023-02-13 | Saulnier (“Saulnier”) | 4.22M | 9.60% |
| 2023-02-13 | Bhaman (“Bhaman”) | 4.22M | 9.60% |
| 2023-02-13 | Capital IX FPCI (“SC IX”) | 4.22M | 9.60% |
| 2023-02-13 | Partners SAS (“SP SAS”) | 4.22M | 9.60% |
| 2023-02-13 | Seghezzi (“Seghezzi”) | 4.22M | 9.60% |
| 2023-02-13 | Papiernik (“Papiernik”) | 4.22M | 9.60% |
| 2023-02-13 | Richter (“Richter”) | 4.22M | 9.60% |
| 2022-09-26 | Corey Goodman | 1.86M | 4.90% |
| 2022-09-26 | venBio Global Strategic GP III, L.P. | 1.86M | 4.90% |
| 2022-09-26 | venBio Global Strategic GP III, Ltd. | 1.86M | 4.90% |
| 2022-09-26 | Robert Adelman | 1.86M | 4.90% |
| 2022-09-26 | venBio Global Strategic Fund III, L.P. | 1.86M | 4.90% |
| 2022-01-21 | 5AM Opportunities I, L.P. | 496.32K | 1.40% |
| 2022-01-21 | 5AM Opportunities I (GP), LLC | 496.32K | 1.40% |
| 2022-01-21 | Robert Atchinson | 2.14M | 5.86% |
| 2022-01-21 | Phillip Gross | 2.14M | 5.86% |
| 2022-01-21 | Andrew J. Schwab | 4.34M | 11.90% |
| 2022-01-21 | General Atlantic GenPar (Bermuda), L.P. | 4.13M | 11.30% |
| 2022-01-21 | General Atlantic GenPar, L.P. | 4.13M | 11.30% |
| 2022-01-21 | Dr. Kush Parmar | 4.34M | 11.90% |
| 2022-01-21 | GAP (Bermuda) L.P. | 4.13M | 11.30% |
| 2022-01-21 | Adage Capital Advisors, L.L.C. | 2.14M | 5.86% |
| 2022-01-21 | General Atlantic, L.P. | 4.13M | 11.30% |
| 2022-01-21 | General Atlantic Partners (Bermuda) EU, L.P. | 4.13M | 11.30% |
| 2022-01-21 | General Atlantic Partners (Lux) SCSp | 4.13M | 11.30% |
| 2022-01-21 | Adage Capital Partners, L.P. | 2.14M | 5.86% |
| 2022-01-21 | Adage Capital Partners GP, L.L.C. | 2.14M | 5.86% |
| 2022-01-21 | General Atlantic GenPar (Lux) SCSp | 4.13M | 11.30% |
| 2022-01-21 | General Atlantic (Lux) S.à r.l. | 4.13M | 11.30% |
| 2022-01-21 | 5AM Ventures VI, L.P. | 3.84M | 10.50% |
| 2022-01-21 | 5AM Partners VI, LLC | 3.84M | 10.50% |
| 2022-01-21 | General Atlantic (CIN), L.P. | 4.13M | 11.30% |
| 2022-01-21 | GAP Coinvestments III, LLC | 4.13M | 11.30% |
| 2022-01-21 | General Atlantic Partners 100 L.P. | 4.13M | 11.30% |
| 2022-01-21 | General Atlantic (SPV) GP, LLC | 4.13M | 11.30% |
| 2022-01-21 | GAP Coinvestments IV, LLC | 4.13M | 11.30% |
| 2022-01-21 | GAP Coinvestments V, LLC | 4.13M | 11.30% |
| 2022-01-21 | GAP Coinvestments CDA, L.P. | 4.13M | 11.30% |
| 2022-01-11 | CinRx Pharma, LLC | 3.63M | 7.80% |
| 2022-01-11 | Aaron Royston | 1.98M | 5.60% |
| 2022-01-11 | venBio Global Strategic GP III, L.P. | 1.98M | 5.60% |
| 2022-01-11 | venBio Global Strategic Fund III, L.P. | 1.98M | 5.60% |
| 2022-01-11 | venBio Global Strategic GP III, Ltd. | 1.98M | 5.60% |
| 2022-01-11 | Robert Adelman | 1.98M | 5.60% |
| 2022-01-11 | Corey Goodman | 1.98M | 5.60% |
CINC Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2021-12-31 | $16.00 | 35.42M | $566.71M | $136.61M | -$ | $430.1M |
| 2020-12-31 | $16.00 | 23.49M | $375.9M | $26.08M | -$ | $349.82M |
| 2019-12-31 | $16.00 | 23.49M | $375.9M | $11.48M | -$ | $364.41M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-09-30 | $32.82 | 40.81M | $1.34B | $292.56M | -$ | $1.05B |
| 2022-06-30 | $18.84 | 37.71M | $710.45M | $127.62M | -$ | $582.84M |
| 2022-03-31 | $17.54 | 33.43M | $586.43M | $164.6M | -$ | $421.82M |
| 2021-12-31 | $16.00 | 35.42M | $566.71M | $136.61M | -$ | $430.1M |
| 2021-09-30 | $16.00 | 35.42M | $566.71M | $141.71M | -$ | $425M |
| 2021-06-30 | $16.00 | 34.36M | $549.82M | -$ | -$ | $549.82M |
| 2021-03-31 | $16.00 | 34.36M | $549.82M | -$ | -$ | $549.82M |
| 2020-12-31 | $16.00 | 23.49M | $375.9M | $26.08M | -$ | $349.82M |